🇺🇸 FDA
Patent

US 8592380

Aerosol foams comprising clindamycin phosphate

granted A61KA61K31/7056A61K9/0014

Quick answer

US patent 8592380 (Aerosol foams comprising clindamycin phosphate) held by Precision Dermatology, Inc. expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision Dermatology, Inc.
Grant date
Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/7056, A61K9/0014, A61K9/12, A61P